These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 38744744)

  • 1. Relationships of emerging biomarkers of cancer cachexia with quality of life, appetite, and cachexia.
    Lipshitz M; Visser J; Anderson R; Nel DG; Smit T; Steel HC; Rapoport BL
    Support Care Cancer; 2024 May; 32(6):349. PubMed ID: 38744744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging markers of cancer cachexia and their relationship to sarcopenia.
    Lipshitz M; Visser J; Anderson R; Nel DG; Smit T; Steel HC; Rapoport B
    J Cancer Res Clin Oncol; 2023 Dec; 149(19):17511-17527. PubMed ID: 37906352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of life and anorexia/cachexia in lung cancer: validation of the Spanish version of the FAACT instrument.
    Arrieta O; Luvián-Morales J; Turcott JG; Oñate-Ocaña LF
    Qual Life Res; 2018 Oct; 27(10):2709-2718. PubMed ID: 29987501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The assessment of anorexia in patients with cancer: cut-off values for the FAACT-A/CS and the VAS for appetite.
    Blauwhoff-Buskermolen S; Ruijgrok C; Ostelo RW; de Vet HCW; Verheul HMW; de van der Schueren MAE; Langius JAE
    Support Care Cancer; 2016 Feb; 24(2):661-666. PubMed ID: 26160463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation and real-world assessment of the Functional Assessment of Anorexia-Cachexia Therapy (FAACT) scale in patients with advanced non-small cell lung cancer and the cancer anorexia-cachexia syndrome (CACS).
    LeBlanc TW; Samsa GP; Wolf SP; Locke SC; Cella DF; Abernethy AP
    Support Care Cancer; 2015 Aug; 23(8):2341-7. PubMed ID: 25586527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brief versions of the FACIT-fatigue and FAACT subscales for patients with non-small cell lung cancer cachexia.
    Salsman JM; Beaumont JL; Wortman K; Yan Y; Friend J; Cella D
    Support Care Cancer; 2015 May; 23(5):1355-64. PubMed ID: 25351456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of Life and Symptom Burden Improve in Patients Attending a Multidisciplinary Clinical Service for Cancer Cachexia: A Retrospective Observational Review.
    Bland KA; Harrison M; Zopf EM; Sousa MS; Currow DC; Ely M; Agar M; Butcher BE; Vaughan V; Dowd A; Martin P
    J Pain Symptom Manage; 2021 Sep; 62(3):e164-e176. PubMed ID: 33652095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer anorexia-cachexia syndrome is characterized by more than one inflammatory pathway.
    Gagnon B; Murphy J; Simonyan D; Penafuerte CA; Sirois J; Chasen M; Tremblay ML
    J Cachexia Sarcopenia Muscle; 2024 Jun; 15(3):1041-1053. PubMed ID: 38481033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between pro-inflammatory cytokines and pain, appetite and fatigue in patients with advanced cancer.
    Paulsen Ø; Laird B; Aass N; Lea T; Fayers P; Kaasa S; Klepstad P
    PLoS One; 2017; 12(5):e0177620. PubMed ID: 28542626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the Cannabis-In-Cachexia-Study-Group.
    ; Strasser F; Luftner D; Possinger K; Ernst G; Ruhstaller T; Meissner W; Ko YD; Schnelle M; Reif M; Cerny T
    J Clin Oncol; 2006 Jul; 24(21):3394-400. PubMed ID: 16849753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of Yukgunja-Tang for treating anorexia in patients with cancer: The protocol for a pilot, randomized, controlled trial.
    Kang HJ; Jeong MK; Park SJ; Jun HJ; Yoo HS
    Medicine (Baltimore); 2019 Oct; 98(40):e16950. PubMed ID: 31577697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab.
    Liu J; Li S; Zhang S; Liu Y; Ma L; Zhu J; Xin Y; Wang Y; Yang C; Cheng Y
    J Clin Lab Anal; 2019 Oct; 33(8):e22964. PubMed ID: 31282096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COMPLETE BLOOD COUNT DERIVED INFLAMMATORY BIOMARKERS IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES.
    Nanava N; Betaneli M; Giorgobiani G; Chikovani T; Janikashvili N
    Georgian Med News; 2020 May; (302):39-44. PubMed ID: 32672687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re-validation and shortening of the Functional Assessment of Anorexia/Cachexia Therapy (FAACT) questionnaire.
    Ribaudo JM; Cella D; Hahn EA; Lloyd SR; Tchekmedyian NS; Von Roenn J; Leslie WT
    Qual Life Res; 2000; 9(10):1137-46. PubMed ID: 11401046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Thrombo-inflammatory Biomarkers in the Prognosis of Cerebral Venous Sinus Thrombosis.
    Karahan SZ; Gazioglu S; Dilaver I; Boz C
    Curr Neurovasc Res; 2021; 18(2):237-243. PubMed ID: 34109909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory biomarkers are correlated with thrombus burden in cerebral venous sinus thrombosis.
    Yaman Kula A; Kurtoğlu AV; Güzel V; Balsak S; Yabacı Tak A; Asil T
    Arq Neuropsiquiatr; 2024 May; 82(5):1-8. PubMed ID: 38811022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase II study with antioxidants, both in the diet and supplemented, pharmaconutritional support, progestagen, and anti-cyclooxygenase-2 showing efficacy and safety in patients with cancer-related anorexia/cachexia and oxidative stress.
    Mantovani G; Macciò A; Madeddu C; Gramignano G; Lusso MR; Serpe R; Massa E; Astara G; Deiana L
    Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):1030-4. PubMed ID: 16702388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of the Chinese version of functional assessment of anorexia-cachexia therapy (FAACT) scale for measuring quality of life in cancer patients with cachexia.
    Zhou T; Yang K; Thapa S; Fu Q; Jiang Y; Yu S
    Support Care Cancer; 2017 Apr; 25(4):1183-1189. PubMed ID: 27900546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of the value of hematological biomarkers in the clinical differential diagnosis of IgG4-RD.
    Karadeniz H; Güler AA; Kardaş RC; Karadeniz M; Paşaoğlu H; Küçük H; Göker B; Tufan A; Öztürk MA
    Turk J Med Sci; 2023 Jun; 53(3):666-674. PubMed ID: 37476904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Functional Assessment of Anorexia/Cachexia Therapy (FAACT) Appetite Scale in veteran cancer patients.
    Chang VT; Xia Q; Kasimis B
    J Support Oncol; 2005; 3(5):377-82. PubMed ID: 16218262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.